Registered entities
Emergence Therapeutics AG
Reg. No. HRB32381Germany
Innovation
3 patent families (1 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 27 times.
| Year | Filings |
|---|---|
| 2024 | 2 |
| 2025 | 2 |
Investor mix
13 investors on record; lead investors include HTGF, Pontifax.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 6 | 46% |
| Private equity | 2 | 15% |
| Bank & private debt | 1 | 8% |
| Other / undisclosed | 4 | 31% |